Is Adeshwar Meditex overvalued or undervalued?

As of 30 October 2025, Adeshwar Meditex's valuation grade has moved from expensive to fair, indicating a shift in its market perception. The company is currently fairly valued. Key ratios include a PE ratio of 12.90, an EV to EBITDA of 8.32, and a Price to Book Value of 0.72, which suggest that the company is positioned reasonably within the market.
In comparison to its peers, Adeshwar Meditex's PE ratio of 12.90 is significantly lower than that of Poly Medicure at 55.91 and Blue Jet Health at 31.35, both categorized as very expensive. This indicates that Adeshwar Meditex may offer a more attractive valuation relative to these peers. Despite a recent decline in stock price, the company's performance over the past month has outpaced the Sensex, returning 7.25% compared to the Sensex's 5.15%.